$YJGJ
YIJIA GROUP CORP.

2024 Q3 Form 10-Q Financial Statement

#000168316824006282 Filed on September 10, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q3
Revenue $108.5K $0.00
YoY Change -100.0%
Cost Of Revenue $35.30K $0.00
YoY Change
Gross Profit $73.17K $0.00
YoY Change
Gross Profit Margin 67.45%
Selling, General & Admin $64.60K $24.25K
YoY Change 166.44% 88.4%
% of Gross Profit 88.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $118.6K $24.25K
YoY Change 389.08% 88.46%
Operating Profit -$45.41K -$24.25K
YoY Change 87.3% -1236.22%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$45.41K -$24.25K
YoY Change 87.3% -1238.36%
Income Tax $9.797K $0.00
% Of Pretax Income
Net Earnings -$55.21K -$24.25K
YoY Change 127.7% -1236.22%
Net Earnings / Revenue -50.9%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 25.01M shares 5.871M shares
Diluted Shares Outstanding 25.01M shares 5.871M shares

Balance Sheet

Concept 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $141.6K
YoY Change
Cash & Equivalents $141.6K $0.00
Short-Term Investments
Other Short-Term Assets $5.491K
YoY Change
Inventory $213.5K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.201M $0.00
YoY Change -100.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.201M $0.00
Total Long-Term Assets $0.00 $0.00
Total Assets $1.201M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $74.67K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $199.4K $83.46K
YoY Change 138.88% 33.03%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $199.4K $83.46K
Total Long-Term Liabilities $0.00
Total Liabilities $199.4K $83.46K
YoY Change 138.88% 33.03%
SHAREHOLDERS EQUITY
Retained Earnings -$38.26K -$148.2K
YoY Change -74.18% 51.88%
Common Stock $25.01K $5.871K
YoY Change 326.03% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.001M -$83.46K
YoY Change
Total Liabilities & Shareholders Equity $1.201M $0.00
YoY Change -100.0%

Cashflow Statement

Concept 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$55.21K -$24.25K
YoY Change 127.7% -1236.22%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$504.0K -$26.15K
YoY Change 1827.57% -485.59%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $52.60K $17.42K
YoY Change 201.97%
NET CHANGE
Cash From Operating Activities -$504.0K -$26.15K
Cash From Investing Activities
Cash From Financing Activities $52.60K $17.42K
Net Change In Cash -$451.4K -$8.728K
YoY Change 5071.87% -228.71%
FREE CASH FLOW
Cash From Operating Activities -$504.0K -$26.15K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
0 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
213463 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
132873 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
5491 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
6079 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
1200851 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
1192858 usd
CY2024Q3 us-gaap Assets
Assets
1200851 usd
CY2024Q2 us-gaap Assets
Assets
1192858 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
67249 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
60749 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1859 usd
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8302 usd
CY2024Q3 YJGJ Due To Related Parties Current1
DueToRelatedPartiesCurrent1
55600 usd
CY2024Q2 YJGJ Due To Related Parties Current1
DueToRelatedPartiesCurrent1
3000 usd
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
74666 usd
CY2024Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
64869 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
199374 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
136920 usd
CY2024Q3 us-gaap Liabilities
Liabilities
199374 usd
CY2024Q2 us-gaap Liabilities
Liabilities
136920 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25012270 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25012270 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25012270 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25012270 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
25012 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
25012 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1012971 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1012971 usd
CY2024Q3 YJGJ Stock To Be Issued Shares
StockToBeIssuedShares
35000 shares
CY2024Q2 YJGJ Stock To Be Issued Shares
StockToBeIssuedShares
20000 shares
CY2024Q3 YJGJ Shares To Be Issued Value
SharesToBeIssuedValue
1750 usd
CY2024Q2 YJGJ Shares To Be Issued Value
SharesToBeIssuedValue
1000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38256 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
16955 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1001477 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1055938 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1200851 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1192858 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108477 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
35304 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
-0 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
73173 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
0 usd
CY2024Q3 us-gaap Selling Expense
SellingExpense
7030 usd
CY2023Q3 us-gaap Selling Expense
SellingExpense
-0 usd
CY2024Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
53984 usd
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
-0 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
57573 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24247 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
118587 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
24247 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-45414 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24247 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9797 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-55211 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-24247 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25012270 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25012270 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5871250 shares
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1055938 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
750 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-55211 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1001477 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-59215 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-24247 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-83462 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-55211 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-24247 usd
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
750 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2024Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
80590 usd
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-0 usd
CY2024Q3 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
379392 usd
CY2023Q3 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-0 usd
CY2024Q3 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-588 usd
CY2023Q3 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-0 usd
CY2024Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6500 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1900 usd
CY2024Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-6443 usd
CY2023Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
0 usd
CY2024Q3 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
9797 usd
CY2023Q3 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-504001 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26147 usd
CY2024Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
52600 usd
CY2023Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
137 usd
CY2024Q3 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
0 usd
CY2023Q3 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
17282 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
52600 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17419 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-451401 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8728 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
593036 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8728 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
141635 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q3 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q3 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_844_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zWB5WPD16DCh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86A_zUAXBkjs99jc">Reclassifications</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain amounts on the prior year’s unaudited condensed consolidated balance sheets, unaudited condensed consolidated statements of operations and cash flows were reclassified to conform to current-year presentation, with no effect on ending stockholders’ equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p>
CY2024Q3 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_z4UCPWb6YpCi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86D_zqLZE2QbAMDi">Use of Estimates and Assumptions</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.15pt; text-align: justify; text-indent: -2.15pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Significant areas for which management uses estimates include:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"> </td> <td style="width: 3%; text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify; width: 94%"><span style="font-size: 10pt">sales returns at point in time and allowances;</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-size: 10pt">inventory;</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-size: 10pt">income tax valuation allowances</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These estimates require the use of judgment as future events, and the effect of these events cannot be predicted with certainty. The estimates will change as new events occur, as more experience is acquired and as more information is obtained. We evaluate and update our assumptions and estimates on an ongoing basis and we may consult outside experts to assist as considered necessary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108477 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108477 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
35304 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
73173 usd
CY2024Q3 us-gaap Selling Expense
SellingExpense
7030 usd
CY2024Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
53984 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
57573 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
118587 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-45414 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
213463 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
132873 usd
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
0 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
0 usd
CY2024Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
9797 usd
CY2023Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9797 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
66146 usd
CY2024Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
46969 usd
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19177 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19177 usd
CY2024Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2024Q3 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0.422 pure
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0.210 pure
CY2024Q3 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.422 pure
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.210 pure
CY2024Q3 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.426 pure
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.210 pure
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.216 pure
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2024Q3 YJGJ Stock To Be Issued Shares
StockToBeIssuedShares
35000 shares
CY2024Q2 YJGJ Stock To Be Issued Shares
StockToBeIssuedShares
20000 shares
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
301267 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-006282-index-headers.html Edgar Link pending
0001683168-24-006282-index.html Edgar Link pending
0001683168-24-006282.txt Edgar Link pending
0001683168-24-006282-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
yijia_ex3101.htm Edgar Link pending
yijia_ex3102.htm Edgar Link pending
yijia_ex3201.htm Edgar Link pending
yijia_i10q-073124.htm Edgar Link pending
yjgj-20240731.xsd Edgar Link pending
yjgj-20240731_def.xml Edgar Link unprocessable
yjgj-20240731_lab.xml Edgar Link unprocessable
yjgj-20240731_pre.xml Edgar Link unprocessable
yijia_i10q-073124_htm.xml Edgar Link completed
yjgj-20240731_cal.xml Edgar Link unprocessable